CNS Pharmaceuticals, Inc. (CNSP) ownership: Top institutional holder: Stonepine Capital Management, LLC ($145790.00). Insider activity: Net Seller (2 buys, 18 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Stonepine Capital Management, LLC | 61000.00 | $145790.00 | 2026-03-31 |
| Ikarian Capital, LLC | 45830.00 | $109992.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 23189.00 | $55653.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 321874.00 | $38754.00 | 2024-12-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 13524.00 | $32322.00 | 2026-03-31 |
| VANGUARD GROUP INC | 58369.00 | $21130.00 | 2024-03-31 |
| Tower Research Capital LLC (TRC) | 1310.00 | $3131.00 | 2026-03-31 |
| UBS Group AG | 729.00 | $1742.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Buy | null | 2026-05-18 | |
| Buy | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 |
Back to CNSP overview · CNSP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.